Literature DB >> 19494080

Human papillomavirus genotype specificity of hybrid capture 2 low-risk probe cocktail.

Mario Poljak1, Bostjan J Kocjan, Anja Kovanda, Maja M Lunar, Snjezana Zidovec Lepej, Ana Planinic, Katja Seme, Adriana Vince.   

Abstract

A genotyping study of 285 Hybrid Capture 2 low-risk probe cocktail-positive specimens showed cross-reactivity with several untargeted human papillomavirus genotypes. Cross-reactivity was often clinically beneficial due to the detection of untargeted low-risk genotypes. A total of 8.4% of positive results, usually weak, were due to cross-reactivity with high-risk genotypes. Establishment of a gray zone is recommended.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19494080      PMCID： PMC2725686          DOI： 10.1128/JCM.00278-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  27 in total

1.  Evaluation of HPV testing by Hybrid Capture II for routine gynecologic screening.

Authors:  P Schneede; P Hillemanns; F Ziller; A Hofstetter; E Stockfleth; R Arndt; T Meyer
Journal:  Acta Obstet Gynecol Scand       Date:  2001-08       Impact factor: 3.636

2.  Hybrid Capture II HPV Test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail.

Authors:  Mario Poljak; Irena J Marin; Katja Seme; Adriana Vince
Journal:  J Clin Virol       Date:  2002-12       Impact factor: 3.168

3.  The borderline or weakly positive Hybrid Capture II HPV test: a statistical and comparative (PCR) analysis.

Authors:  Jerome M Federschneider; Liping Yuan; Joshua Brodsky; Gillian Breslin; Rebecca A Betensky; Christopher P Crum
Journal:  Am J Obstet Gynecol       Date:  2004-09       Impact factor: 8.661

4.  Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group.

Authors: 
Journal:  J Natl Cancer Inst       Date:  2000-03-01       Impact factor: 13.506

5.  Hybrid capture-II and LCR-E7 PCR assays for HPV typing in cervical cytologic samples.

Authors:  H Yamazaki; T Sasagawa; W Basha; T Segawa; M Inoue
Journal:  Int J Cancer       Date:  2001-10-15       Impact factor: 7.396

6.  Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types.

Authors:  Philip E Castle; Mark Schiffman; Robert D Burk; Sholom Wacholder; Allan Hildesheim; Rolando Herrero; M Concepcion Bratti; Mark E Sherman; Attila Lorincz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-11       Impact factor: 4.254

7.  Efficiency of the hybrid capture 2 HPV DNA test in cervical cancer screening. A study by the French Society of Clinical Cytology.

Authors:  Patricia de Cremoux; Joël Coste; Xavier Sastre-Garau; Martine Thioux; Christelle Bouillac; Sylvain Labbé; Isabelle Cartier; Marianne Ziol; Anne Dosda; Catherine Le Galès; Vincent Molinié; Marie-Cécile Vacher-Lavenu; Béatrix Cochand-Priollet; Philippe Vielh; Henri Magdelénat
Journal:  Am J Clin Pathol       Date:  2003-10       Impact factor: 2.493

Review 8.  Classification of papillomaviruses.

Authors:  Ethel-Michele de Villiers; Claude Fauquet; Thomas R Broker; Hans-Ulrich Bernard; Harald zur Hausen
Journal:  Virology       Date:  2004-06-20       Impact factor: 3.616

9.  Identification of human papilloma viruses in male dysplastic genital lesions.

Authors:  C Dianzani; S Calvieri; A Pierangeli; A M Degener
Journal:  New Microbiol       Date:  2004-01       Impact factor: 2.479

10.  Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older.

Authors:  Chris J L M Meijer; Johannes Berkhof; Philip E Castle; Albertus T Hesselink; Eduardo L Franco; Guglielmo Ronco; Marc Arbyn; F Xavier Bosch; Jack Cuzick; Joakim Dillner; Daniëlle A M Heideman; Peter J F Snijders
Journal:  Int J Cancer       Date:  2009-02-01       Impact factor: 7.396
View more
  2 in total

1.  Human Papillomavirus in Brazilian women with and without cervical lesions.

Authors:  Michelle Oliveira-Silva; Camila X Lordello; Lucília M G Zardo; Cibele R Bonvicino; Miguel A M Moreira
Journal:  Virol J       Date:  2011-01-05       Impact factor: 4.099

2.  Self-Sampling for Human Papillomavirus Testing among Non-Attenders Increases Attendance to the Norwegian Cervical Cancer Screening Programme.

Authors:  Espen Enerly; Jesper Bonde; Kristina Schee; Helle Pedersen; Stefan Lönnberg; Mari Nygård
Journal:  PLoS One       Date:  2016-04-13       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.